Molecular counting enables accurate and precise quantification of methylated ctDNA for tumor-naive cancer therapy response monitoring
Abstract Personalized cancer treatment can significantly extend survival and improve quality of life for many patients, but accurate and real-time therapy response monitoring remains challenging. To overcome logistical and technical challenges associated with therapy response monitoring via imaging...
Saved in:
| Main Authors: | Patrick Peiyong Ye, Robb Viens, Katherine E Shelburne, Sydne Scot Langpap, Xavier S Bower, Jonathan Jiahui Shi, Wen Zhou, Jan Christian Wignall, Joyce Jiawei Zhu, Brian D. Woodward, Hatim Husain, David S. Tsao, Oguzhan Atay |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-02-01
|
| Series: | Scientific Reports |
| Online Access: | https://doi.org/10.1038/s41598-025-90013-3 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparison of tumor‐informed and tumor‐naïve sequencing assays for ctDNA detection in breast cancer
by: Angela Santonja, et al.
Published: (2023-05-01) -
Molecular clustering on ctDNA improves the prognostic stratification of patients with DLBCL compared with ctDNA levels
by: Riccardo Moia, et al.
Published: (2025-04-01) -
Utility of Germline, Somatic and ctDNA Testing in Adults With Cancer
by: Emily DeBortoli, et al.
Published: (2025-08-01) -
The role of renal and liver function in clinical ctDNA testing.
by: Jens Bo Koudahl Conrad, et al.
Published: (2025-01-01) -
The role of circulating tumor DNA (ctDNA) in urothelial cancers
by: Jeanny B. Aragon-Ching
Published: (2025-05-01)